İnsan çevirisi örneklerinden çeviri yapmayı öğrenmeye çalışıyor.
Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
the national statistical offices , the national central banks and other competent national authorities responsible for data collections have been consulted on many occasions during the preparation of this text .
the national statistical offices , the national central banks and other competent national authorities responsible for data collections have been consulted on many occasions during the preparation of this text .
it can consist of research tasks , the preparation of draft reports , the compilation of statistical data , the execution of operational tasks and the participation in ad hoc studies .
it can consist of research tasks , the preparation of draft reports , the compilation of statistical data , the execution of operational tasks and the participation in ad hoc studies .
marginale antal swappoint, det( marginal swap point quotation): det antal swappoint, ved hvilket hele tildelingsbeløbet i en auktion er nået.
operazione di fine tuning( fine tuning operation): operazione di mercato aperto utilizzata, all' occorrenza, dall' eurosistema principalmente per far fronte a variazioni inattese della liquidità sul mercato.
marginale antal swappoint , det ( marginal swap point quotation ) : det antal swappoint , ved hvilket hele tildelingsbeløbet i en auktion er nået .
in alcuni casi particolari , il calendario può essere modificato dopo la pubblicazione , ad esempio in seguito a variazioni nella programmazione delle riunioni del consiglio direttivo . prezzo di acquisto [ purchase price ] : prezzo al quale è venduta o deve essere venduta l' attività oggetto della transazione .
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow- acting anti- rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications: